Citius Pharmaceuticals, Inc. (CTXR): Net Income
-$39.74M
Year ended 2025-09-30
-$58.17M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$39.74M | n/m | 2025-12-23, From 2024-10-01 |
| 2024-09-30 | -$39.43M | n/m | 2025-12-23, From 2023-10-01 |
| 2023-09-30 | -$32.54M | n/m | 2024-12-27, From 2022-10-01 |
| 2022-09-30 | -$33.64M | n/m | 2023-12-29, From 2021-10-01 |
| 2021-09-30 | -$23.05M | n/m | 2022-12-22, From 2020-10-02 |
| 2020-09-30 | -$17.55M | n/m | 2021-12-15, From 2019-10-01 |
| 2019-09-30 | -$15.56M | n/m | 2020-12-16, From 2018-10-01 |
| 2018-09-30 | -$12.54M | n/m | 2019-12-16, From 2017-10-01 |
| 2017-09-30 | -$10.38M | n/m | 2019-12-16, From 2016-10-01 |
| 2016-09-30 | -$8.30M | n/m | 2018-12-11, From 2015-10-01 |
| 2015-09-30 | -$2.90M | n/m | 2017-12-13, From 2014-10-01 |
| 2014-09-30 | -$737.7K | n/m | 2016-12-23, From 2013-10-01 |
| 2013-09-30 | -$31.4K | n/m | 2014-02-06, From 2012-10-01 |
| 2012-09-30 | -$22.0K | n/m | 2014-02-06, From 2011-10-01 |
| 2011-09-30 | -$26.3K | n/m | 2014-02-06, From 2010-10-01 |
| 2010-09-30 | -$15.5K | n/a | 2014-02-06, From 2009-10-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | 2025-09-30 | -$39.74M | n/m |
| Silence Therapeutics plc (SLN) | 2025-12-31 | -$88.61M | n/m |
| Acrivon Therapeutics, Inc. (ACRV) | 2025-12-31 | -$77.91M | n/m |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | -$81.86M | n/m |
| Seres Therapeutics, Inc. (MCRB) | 2025-12-31 | $5.70M | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $44.87M | n/m |
| Monopar Therapeutics (MNPR) | 2025-12-31 | -$13.72M | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | -$99.50M | n/m |
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | $183.45M | n/m |
Compare CTXR, SLN, ACRV, ZOMDF side by side · Screen every company in Pharmaceutical Preparations ↗